investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT

Helen E. Heslop

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Leukaemia

Oliver W. Press

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Leukaemia

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Richard John O'Reilly

Immunobiology for Marrow Allografts for Leukemia

Leukaemia

Pier Paolo Pandolfi

Targeting Tumor Suppressive Pathways for Cancer Therapy

Leukaemia

A. Thomas Look

Discovery of New Targets and Pathways for T-ALL Therapy

Leukaemia

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Hematology and hematologic malignancies Pathology

Aude Chapuis

Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W

Leukaemia

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia